Proper dosing protocolstypically 250-500 mcg daily via subcutaneous injection in a fasted stateprovide the foundation for optimal results while minimizing side effects
The nearest we have come to an answer so far is the initial trialling by the Pernicious Anaemia Society - which found a significant difference between those who can function well on the NHS frequency and those who are unable to do so
(NOTE: It was very interesting to see how only IV infusions or oral formulations were used in the clinical trials for a peptide designed to LOSE BODY FAT, which probably explains why Metabolic Pharmaceuticals was unable to get favorable weight loss results but thats just me) And while some peptide clinics endorse combining AOD-9604 with NAD+, but I personally cannot vouch for this
BPC-157 is supplied strictly for qualified in-vitro laboratory research
Mucosal Healing : Promotes regeneration of the intestinal lining damaged by chronic inflammation, repairing ulcers and lesions common in Crohns disease
Anti-Inflammatory & Cytoprotective Actions Studies indicate that BPC-157 regulates inflammatory cytokines and oxidative stress markers, reducing cellular damage in injury models